Printer Friendly

UPJOHN AND PARTNER TO MARKET DEPO-PROVERA IN INDIA

 KALAMAZOO, Mich., Oct. 5 /PRNewswire/ -- The Upjohn Company (NYSE: UPJ) and Max India Limited of New Delhi have reached agreement for the sale and distribution of Depo-Provera Contraceptive Injection to physicians in India, according to Upjohn, maker of Depo-Provera. On June 11, 1993, the government of India granted Upjohn permission to market Depo-Provera in that country.
 The agreement with the Indian drug company also grants that company the rights to sell and distribute Depo-Provera in Nepal and Bhutan.
 Upjohn President and acting Chief Executive Officer Ley S. Smith said, "As the Indian people continue to deal with the population issue in their country, the availability of a variety of contraception options is vital. We're pleased that Upjohn will be able to make this safe and effective option available."
 "More than 30 million women worldwide have used Depo-Provera since it was first introduced for contraceptive use in 1969 in New Zealand," said Smith. Depo-Provera is currently available in more than 90 countries around the world. Approvals were also granted, according to Smith, in Venezuela and Chile in August of this year. It has been marketed in the United States since January 1993.
 In clinical studies, Depo-Provera was more than 99 percent effective, making it one of the most reliable birth control methods available. This effectiveness rate, as well as the fact that the patient needs to be injected only once every three months, makes the product a practical option for women, said Smith.
 The Upjohn Company is a worldwide, research-based provider of human health care products, animal health products, agronomic and vegetable seeds and
specialty chemicals. Headquartered in Kalamazoo, Mich., the company has been dedicated to improving health and nutrition for more than a century.
 -0- 10/5/93
 /CONTACT: Kaye Bennett of The Upjohn Company, 616-323-4224/
 (UPJ)


CO: The Upjohn Company; Max India Limited ST: Michigan IN: MTC SU:

JG -- DE005 -- 8734 10/05/93 09:24 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 5, 1993
Words:318
Previous Article:BACKGROUND: NATURAL GAS PRODUCERS' VIEW OF NAFTA
Next Article:MARION MERRELL DOW COMPLETES ACQUISITION OF AMERICA'S LARGEST GENERIC DRUG COMPANY
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters